ABBV
AbbVie Inc.
NYSE · USHealthcareDrug Manufacturers - General
$253.38-0.44%
Price as of Jul 20, 2026
ABBV profitability
AbbVie Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 70.7%
- EBITDA margin
- 26.9%
- EBIT margin
- 27.6%
- Net margin
- 5.8%
- Free cash flow margin
- 33.2%
Returns
- Return on equity
- 13.2%
- Return on assets
- 2.7%
- Return on invested capital
- 17.3%
- Asset turnover
- 0.46x
Cash efficiency
- Cash from operations
- $21.2B
- Cash per share
- $5.32
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.